PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of hsresearchLink to Publisher's site
 
Health Serv Res. 2001 December; 36(6 Pt 1): 1085–1107.
PMCID: PMC1089280

Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods.

Abstract

OBJECTIVE. The burden of illness can influence treatment decisions, but there are limited data comparing the performance of different illness burden measures. We assessed the correlations between five previously validated measures of illness burden and global health and physical function and evaluated how each measure correlates with breast cancer treatment patterns in older women. DATA SOURCE: A cohort of 718 women > 67 years with early-stage breast cancer formed the study group. STUDY DESIGN/DATA COLLECTION METHODS: The study made a cross-sectional comparison of illness burden measures (Charlson index, Index of Co-existent Diseases, cardiopulmonary burden of illness, patient-specific life expectancy, and disease counts) and physical function and self-rated global health status. Data were collected from records and patient interviews. PRINCIPAL FINDINGS: All of the measures were significantly correlated with each other and with physical function and self-rated health (p < .001). After controlling for age and stage, life expectancy had the largest effect on surgical treatment, followed by self-rated physical function and health; life expectancy was also independent of physical function. For instance, women with higher life expectancy and better self-rated physical function and health were more likely to receive breast conservation and radiation than sicker women. Women with higher physical functioning were more likely to receive adjuvant chemotherapy than women with lower functioning. CONCLUSIONS: Several measures of illness burden were associated with breast cancer therapy, but each measure accounted for only a small amount of variance in treatment patterns. Future work is needed to develop and validate measures of burden of illness that are feasible, comprehensive, and relevant for diverse clinical and health services objectives.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol. 1996 Jul;156(1):127–132. [PubMed]
  • Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996 Jun 5;88(11):716–726. [PubMed]
  • Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med. 1982 Dec;73(6):883–888. [PubMed]
  • Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP. A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med. 1982 Dec;73(6):889–897. [PubMed]
  • Bennahum DA, Forman WB, Vellas B, Albarede JL. Life expectancy, comorbidity, and quality of life. A framework of reference for medical decisions. Clin Geriatr Med. 1997 Feb;13(1):33–53. [PubMed]
  • Bergman L, Dekker G, van Kerkhoff EH, Peterse HL, van Dongen JA, van Leeuwen FE. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treat. 1991 Aug;18(3):189–198. [PubMed]
  • Brailer DJ, Kroch E, Pauly MV, Huang J. Comorbidity-adjusted complication risk: a new outcome quality measure. Med Care. 1996 May;34(5):490–505. [PubMed]
  • Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med. 1992 Feb;8(1):1–17. [PubMed]
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. [PubMed]
  • Chen AY, Daley J, Thibault GE. Angina patients' ratings of current health and health without angina: associations with severity of angina and comorbidity. Med Decis Making. 1996 Apr-Jun;16(2):169–177. [PubMed]
  • Chin MH, Goldman L. Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol. 1997 Jun 15;79(12):1640–1644. [PubMed]
  • Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA. 1992 Feb 26;267(8):1077–1082. [PubMed]
  • Desch CE, Penberthy L, Newschaffer CJ, Hillner BE, Whittemore M, McClish D, Smith TJ, Retchin SM. Factors that determine the treatment for local and regional prostate cancer. Med Care. 1996 Feb;34(2):152–162. [PubMed]
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6):613–619. [PubMed]
  • Eachus J, Chan P, Pearson N, Propper C, Davey Smith G. An additional dimension to health inequalities: disease severity and socioeconomic position. J Epidemiol Community Health. 1999 Oct;53(10):603–611. [PMC free article] [PubMed]
  • Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8–27. [PubMed]
  • Ershler WB, Longo DL. Aging and cancer: issues of basic and clinical science. J Natl Cancer Inst. 1997 Oct 15;89(20):1489–1497. [PubMed]
  • Extermann M, Balducci L, Lyman GH. What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol. 2000 Apr;18(8):1709–1717. [PubMed]
  • Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998 Apr;16(4):1582–1587. [PubMed]
  • Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995 Nov 30;333(22):1456–1461. [PubMed]
  • Fox SA, Siu AL, Stein JA. The importance of physician communication on breast cancer screening of older women. Arch Intern Med. 1994 Sep 26;154(18):2058–2068. [PubMed]
  • Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of comorbidity with disability in older women: the Women's Health and Aging Study. J Clin Epidemiol. 1999 Jan;52(1):27–37. [PubMed]
  • Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol. 1999 Nov;26(11):2475–2479. [PubMed]
  • Gabriel SE, Crowson CS, O'Fallon WM. A comparison of two comorbidity instruments in arthritis. J Clin Epidemiol. 1999 Dec;52(12):1137–1142. [PubMed]
  • Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst. 1996 Aug 7;88(15):1031–1038. [PubMed]
  • Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993 Feb;31(2):141–154. [PubMed]
  • Greenfield S, Aronow HU, Elashoff RM, Watanabe D. Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA. 1988 Oct 21;260(15):2253–2255. [PubMed]
  • Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA. 1987 May 22;257(20):2766–2770. [PubMed]
  • Guadagnoli E, Cleary PD. How consistent is patient-reported pre-admission health status when collected during and after hospital stay? Med Care. 1995 Jan;33(1):106–112. [PubMed]
  • Guadagnoli E, Shapiro C, Gurwitz JH, Silliman RA, Weeks JC, Borbas C, Soumerai SB. Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer. J Clin Oncol. 1997 Jun;15(6):2338–2344. [PubMed]
  • Holland RR, Ellis CA, Geller BM, Plante DA, Secker-Walker RH. Life expectancy estimation with breast cancer: bias of the declining exponential function and an alternative to its use. Med Decis Making. 1999 Oct-Dec;19(4):385–393. [PubMed]
  • Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996 Jan;34(1):73–84. [PubMed]
  • Krop JS, Powe NR, Weller WE, Shaffer TJ, Saudek CD, Anderson GF. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care. Diabetes Care. 1998 May;21(5):747–752. [PubMed]
  • Krousel-Wood MA, Abdoh A, Re R. Comparing comorbid-illness indices assessing outcome variation: the case of prostatectomy. J Gen Intern Med. 1996 Jan;11(1):32–38. [PubMed]
  • Lash TL, Silliman RA. Re: prevalence of cancer. J Natl Cancer Inst. 1998 Mar 4;90(5):399–400. [PubMed]
  • Macleod U, Ross S, Twelves C, George WD, Gillis C, Watt GC. Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records. BMJ. 2000 May 27;320(7247):1442–1445. [PMC free article] [PubMed]
  • Mandelblatt JS, Ganz PA, Kahn KL. Proposed agenda for the measurement of quality-of-care outcomes in oncology practice. J Clin Oncol. 1999 Aug;17(8):2614–2622. [PubMed]
  • Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer. 2000 Aug 1;89(3):561–573. [PubMed]
  • McGee D, Cooper R, Liao Y, Durazo-Arvizu R. Patterns of comorbidity and mortality risk in blacks and whites. Ann Epidemiol. 1996 Sep;6(5):381–385. [PubMed]
  • Mort EA, Guadagnoli E, Schroeder SA, Greenfield S, Mulley AG, McNeil BJ, Cleary PD. The influence of age on clinical and patient-reported outcomes after cholecystectomy. J Gen Intern Med. 1994 Feb;9(2):61–65. [PubMed]
  • Mulrow CD, Gerety MB, Cornell JE, Lawrence VA, Kanten DN. The relationship between disease and function and perceived health in very frail elders. J Am Geriatr Soc. 1994 Apr;42(4):374–380. [PubMed]
  • Newschaffer CJ, Penberthy L, Desch CE, Retchin SM, Whittemore M. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. Arch Intern Med. 1996 Jan 8;156(1):85–90. [PubMed]
  • Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW., Jr Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998 Jan-Feb;48(1):31–48. [PubMed]
  • Pressley JC, Patrick CH. Frailty bias in comorbidity risk adjustments of community-dwelling elderly populations. J Clin Epidemiol. 1999 Aug;52(8):753–760. [PubMed]
  • Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994 Jan 15;120(2):104–110. [PubMed]
  • Shwartz M, Iezzoni LI, Moskowitz MA, Ash AS, Sawitz E. The importance of comorbidities in explaining differences in patient costs. Med Care. 1996 Aug;34(8):767–782. [PubMed]
  • Silliman RA, Lash TL. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients. Med Care. 1999 Apr;37(4):339–349. [PubMed]
  • Silliman RA, Troyan SL, Guadagnoli E, Kaplan SH, Greenfield S. The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer. 1997 Oct 1;80(7):1326–1334. [PubMed]
  • Stein RE, Gortmaker SL, Perrin EC, Perrin JM, Pless IB, Walker DK, Weitzman M. Severity of illness: concepts and measurements. Lancet. 1987 Dec 26;2(8574):1506–1509. [PubMed]
  • Stewart AL, Hays RD, Ware JE., Jr The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988 Jul;26(7):724–735. [PubMed]
  • Stier DM, Greenfield S, Lubeck DP, Dukes KA, Flanders SC, Henning JM, Weir J, Kaplan SH. Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer. Urology. 1999 Sep;54(3):424–429. [PubMed]
  • Taplin SH, Barlow W, Urban N, Mandelson MT, Timlin DJ, Ichikawa L, Nefcy P. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995 Mar 15;87(6):417–426. [PubMed]
  • West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996 Sep;6(5):413–419. [PubMed]
  • Yancik R, Wesley MN, Ries LA, Havlik RJ, Long S, Edwards BK, Yates JW. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998 Jun 1;82(11):2123–2134. [PubMed]

Articles from Health Services Research are provided here courtesy of Health Research & Educational Trust